TP53 and breast cancer: For example, harmaline can suppress the growth of liver cancer cells by inducing the p53/p21 and Fas/FasL signaling pathways [25], and may have therapeutic potential for controlling breast cancer invasiveness [26], and chloroxine can facilitate platinum-induced DNA damage to induce cancer cell death in high-grade serous cancer [27].